Danaher has reported solid financial performance, with revenue growing from $6.5B in 4Q 2024 to $6.1B in the most recent 4Q 2025. Net margins have expanded from 9.5% in 4Q 2024 to 13.6% in 4Q 2025, a meaningful improvement. This margin expansion has been driven by Danaher's disciplined M&A strategy, which has allowed the company to integrate and optimize acquired businesses. The data shows ROIC has also improved from 4.3% to 4.3% over the same period. Danaher's diversified end markets, which include healthcare, life sciences, and environmental/applied solutions, have proven resilient and continue to benefit from favorable secular trends like aging demographics and sustainability initiatives. This has supported the company's pricing power and operating leverage. Given Danaher's track record of successful acquisitions, ongoing cost optimization efforts, and exposure to attractive end markets, I believe the company can sustain its margin expansion trajectory. I see potential for net margins to reach 15-16% over the next 12-18 months. At the current price of $204.73, Danaher appears reasonably valued at around 22x forward earnings. I believe the stock is attractively priced considering the company's margin expansion potential and its history of strong operational execution. This makes Danaher a compelling investment opportunity in the industrial technology space.

1 Reply

Research these companies